Sfoglia per Autore
Does the neobladder filling modulate soleus H reflex?
2014-01-01 Palleschi, G; Conte, A; Pastore, Al; Salerno, G; Morgia, G; Giannantoni, Antonella; Berardelli, A; Carbone, A.
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis
2014-01-01 Di Filippo, M; Proietti, S; Gaetani, L; Gubbiotti, M; Di Gregorio, M; Eusebi, P; Calabresi, P; Sarchielli, P; Giannantoni, A
The efficacy and safety of a multimodal therapy for chronic prostatitis/chronic pelvic pain: a prospective randomized study
2013-01-01 Giannantoni, Antonella; Proietti, S.; Gubbiotti, M.; Rossi De Vermanodis, J. A.; Porena, Massimo
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis
2013-01-01 Proietti, S.; Di Filippo, M.; Sarchielli, P.; Gubbiotti, M; Rossi De Vermandois, Ja; Gaetani, L.; Calabresi, P.; Giannantoni, A
Urinary symptoms and sexual dysfunction in patients affected by multiple sclerosis
2013-01-01 Proietti, S; Gubbiotti, M; Rossi de Vermandois, Ja; Porena, M; Giannantoni, A
Urinary symptoms and sexual dysfunction in patients affected by multiple sclerosis
2013-01-01 Giannantoni, A; Proietti, S; Gubbiotti, M; Rossi De Vermandois, J A; Porena, M.
The efficacy and safety of a multimodal therapy for chronic prostatitis/chronic pelvic pain: a psospective randomized study
2013-01-01 Giannantoni, A; Gubbiotti, M; Rossi de Vermandois, Ja; Porena, M
Desmopressin in the treatment of nocturia in patients affected by Parkinson's disease
2013-01-01 Giannantoni, A.; Proietti, S.; Gubbiotti, M.; Rossi De Vermandois, J. A.
Three-Year Follow-Up of Botulinum Toxin A Intradetrusorial Injections in Patients with Parkinson’s disease and refractory neurogenic detrusor overactivity: clinical and urodynamic results
2013-01-01 Giannantoni, A; Proietti, S; Gubbiotti, M; Rossi de Vermandois, J. A.; Porena, M
Urinary symptoms and sexual dysfunction in patients affected by Multiple Sclerosis
2013-01-01 Giannantoni, A; Proietti, S; Gubbiotti, M; Rossi de Vermandois, Ja; Porena, M
Evaluation of H - reflex in patients with ileal orthotopic neobladder
2013-01-01 Palleschi, G.; Pastore, A. L.; Morgia, G.; Salerno, G.; Giannantoni, A.; Conte, A.; Berardelli, A.; Carbone, A.
Onabotulinumtoxin-A intradetrusorial injections modulate bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity
2013-01-01 Giannantoni, A; Conte, A; Farfariello, V; Proietti, S; Vianello, A; Nardicchi, V; Santoni, G; Amantini, C.
Botulinum toxin Type-A activity in prostate cancer
2012-01-01 Proietti, S.; Nardicchi, V.; Porena, M.; Giannantoni, A.
Expression and distribution of botulinum A toxin high affinity receptors in normal human urothelial cell lines
2012-01-01 Giannantoni, A; Proietti, S; Farfariello, V; Lolli, C; Lepri, L; Gubbiotti, M; Amantini, C.
Dyssynergia or asynergia?
2012-01-01 Athanasopoulos, A; Giannantoni, A.
Overactive bladder and sexual function: a nightmare couple
2012-01-01 Proietti, S; Giannantoni, A; Sahai, A; Khan, M. S.; Dasgupta, P
Normal human urothelial cell lines express onabotulinumtoxinA SV2 high affinity receptors
2012-01-01 Giannantoni, A.; Amantini, C.; Proietti, S.; Farfariello, V.; Vianello, A.; Santoni, G.; Porena, M.
OnabotulinumtoxinA intradetrusorial injections modulates bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity
2012-01-01 Giannantoni, A.; Amantini, C.; Proietti, S.; Farfariello, V.; Nardicchi, V.; Santoni, G.; Porena, M.
OnabotulinumtoxinA intradetrusorial injections modulates bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity
2012-01-01 Giannantoni, A; Proietti, S; Farfariello, V; Lolli, C; Lepri, L; Gubbiotti, M; Amantini, C.
“Efficacy and tolerability of fesoterodine fumarate in the treatment of overactive bladder symptoms in patients affected by Multiple Sclerosis: Long term follow up”
2012-01-01 S., Proietti; Lepri, E.; Lepri, L.; Lolli, C.; Gubbiotti, M.; Giannantoni, A.
Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
---|---|---|---|---|
Does the neobladder filling modulate soleus H reflex? | 1-gen-2014 | Palleschi, G; Conte, A; Pastore, Al; Salerno, G; Morgia, G; Giannantoni, Antonella; Berardelli, A; Carbone, A. | - | |
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis | 1-gen-2014 | Di Filippo, M; Proietti, S; Gaetani, L; Gubbiotti, M; Di Gregorio, M; Eusebi, P; Calabresi, P; Sarchielli, P; Giannantoni, A | - | |
The efficacy and safety of a multimodal therapy for chronic prostatitis/chronic pelvic pain: a prospective randomized study | 1-gen-2013 | Giannantoni, Antonella; Proietti, S.; Gubbiotti, M.; Rossi De Vermanodis, J. A.; Porena, Massimo | - | |
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis | 1-gen-2013 | Proietti, S.; Di Filippo, M.; Sarchielli, P.; Gubbiotti, M; Rossi De Vermandois, Ja; Gaetani, L.; Calabresi, P.; Giannantoni, A | - | |
Urinary symptoms and sexual dysfunction in patients affected by multiple sclerosis | 1-gen-2013 | Proietti, S; Gubbiotti, M; Rossi de Vermandois, Ja; Porena, M; Giannantoni, A | - | |
Urinary symptoms and sexual dysfunction in patients affected by multiple sclerosis | 1-gen-2013 | Giannantoni, A; Proietti, S; Gubbiotti, M; Rossi De Vermandois, J A; Porena, M. | - | |
The efficacy and safety of a multimodal therapy for chronic prostatitis/chronic pelvic pain: a psospective randomized study | 1-gen-2013 | Giannantoni, A; Gubbiotti, M; Rossi de Vermandois, Ja; Porena, M | - | |
Desmopressin in the treatment of nocturia in patients affected by Parkinson's disease | 1-gen-2013 | Giannantoni, A.; Proietti, S.; Gubbiotti, M.; Rossi De Vermandois, J. A. | - | |
Three-Year Follow-Up of Botulinum Toxin A Intradetrusorial Injections in Patients with Parkinson’s disease and refractory neurogenic detrusor overactivity: clinical and urodynamic results | 1-gen-2013 | Giannantoni, A; Proietti, S; Gubbiotti, M; Rossi de Vermandois, J. A.; Porena, M | - | |
Urinary symptoms and sexual dysfunction in patients affected by Multiple Sclerosis | 1-gen-2013 | Giannantoni, A; Proietti, S; Gubbiotti, M; Rossi de Vermandois, Ja; Porena, M | - | |
Evaluation of H - reflex in patients with ileal orthotopic neobladder | 1-gen-2013 | Palleschi, G.; Pastore, A. L.; Morgia, G.; Salerno, G.; Giannantoni, A.; Conte, A.; Berardelli, A.; Carbone, A. | - | |
Onabotulinumtoxin-A intradetrusorial injections modulate bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity | 1-gen-2013 | Giannantoni, A; Conte, A; Farfariello, V; Proietti, S; Vianello, A; Nardicchi, V; Santoni, G; Amantini, C. | - | |
Botulinum toxin Type-A activity in prostate cancer | 1-gen-2012 | Proietti, S.; Nardicchi, V.; Porena, M.; Giannantoni, A. | - | |
Expression and distribution of botulinum A toxin high affinity receptors in normal human urothelial cell lines | 1-gen-2012 | Giannantoni, A; Proietti, S; Farfariello, V; Lolli, C; Lepri, L; Gubbiotti, M; Amantini, C. | - | |
Dyssynergia or asynergia? | 1-gen-2012 | Athanasopoulos, A; Giannantoni, A. | - | |
Overactive bladder and sexual function: a nightmare couple | 1-gen-2012 | Proietti, S; Giannantoni, A; Sahai, A; Khan, M. S.; Dasgupta, P | - | |
Normal human urothelial cell lines express onabotulinumtoxinA SV2 high affinity receptors | 1-gen-2012 | Giannantoni, A.; Amantini, C.; Proietti, S.; Farfariello, V.; Vianello, A.; Santoni, G.; Porena, M. | - | |
OnabotulinumtoxinA intradetrusorial injections modulates bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity | 1-gen-2012 | Giannantoni, A.; Amantini, C.; Proietti, S.; Farfariello, V.; Nardicchi, V.; Santoni, G.; Porena, M. | - | |
OnabotulinumtoxinA intradetrusorial injections modulates bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity | 1-gen-2012 | Giannantoni, A; Proietti, S; Farfariello, V; Lolli, C; Lepri, L; Gubbiotti, M; Amantini, C. | - | |
“Efficacy and tolerability of fesoterodine fumarate in the treatment of overactive bladder symptoms in patients affected by Multiple Sclerosis: Long term follow up” | 1-gen-2012 | S., Proietti; Lepri, E.; Lepri, L.; Lolli, C.; Gubbiotti, M.; Giannantoni, A. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile